Herceptin
NDC 50242-132, Trastuzumab, injection, powder, lyophilized, for solution, from Genentech, Inc..
- Product NDC
- 50242-132
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA103792
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRASTUZUMAB150 mg/7.4mL
Pharmacologic classes
HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-132-01 | 50242013201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-132-01) / 15 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/492dbdb2-077e-4064-bff3-372d6af0a7a2Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50242-132
Use it
Look up 50242-132 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.